ES2061247T3 - Imidazo (4,5-c) piridinas con actividad antagonista del paf. - Google Patents

Imidazo (4,5-c) piridinas con actividad antagonista del paf.

Info

Publication number
ES2061247T3
ES2061247T3 ES91909431T ES91909431T ES2061247T3 ES 2061247 T3 ES2061247 T3 ES 2061247T3 ES 91909431 T ES91909431 T ES 91909431T ES 91909431 T ES91909431 T ES 91909431T ES 2061247 T3 ES2061247 T3 ES 2061247T3
Authority
ES
Spain
Prior art keywords
paf
imidazo
piridinas
antagonist activity
leucotrene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91909431T
Other languages
English (en)
Spanish (es)
Inventor
Anthony Marfat
James Frederick Eggler
Kevin Cooper
Michael Jonathan Fray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2061247T3 publication Critical patent/ES2061247T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES91909431T 1990-05-09 1991-05-01 Imidazo (4,5-c) piridinas con actividad antagonista del paf. Expired - Lifetime ES2061247T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09

Publications (1)

Publication Number Publication Date
ES2061247T3 true ES2061247T3 (es) 1994-12-01

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91909431T Expired - Lifetime ES2061247T3 (es) 1990-05-09 1991-05-01 Imidazo (4,5-c) piridinas con actividad antagonista del paf.

Country Status (28)

Country Link
EP (1) EP0533695B1 (en, 2012)
JP (1) JPH0678340B2 (en, 2012)
CN (1) CN1057839A (en, 2012)
AP (1) AP224A (en, 2012)
AT (1) ATE112567T1 (en, 2012)
AU (1) AU642265B2 (en, 2012)
BG (1) BG97059A (en, 2012)
BR (1) BR9106433A (en, 2012)
CA (1) CA2080476A1 (en, 2012)
DE (1) DE69104481T2 (en, 2012)
DK (1) DK0533695T3 (en, 2012)
ES (1) ES2061247T3 (en, 2012)
FI (1) FI925053A0 (en, 2012)
GT (1) GT199100031A (en, 2012)
HU (1) HUT62894A (en, 2012)
IE (1) IE911553A1 (en, 2012)
IL (1) IL98075A0 (en, 2012)
MA (1) MA22151A1 (en, 2012)
MY (1) MY105512A (en, 2012)
NO (1) NO924290D0 (en, 2012)
NZ (1) NZ238089A (en, 2012)
PE (1) PE26691A1 (en, 2012)
PT (1) PT97616A (en, 2012)
RO (1) RO109450B1 (en, 2012)
TW (1) TW205549B (en, 2012)
WO (1) WO1991017163A1 (en, 2012)
YU (1) YU81191A (en, 2012)
ZA (1) ZA913497B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
CN1308622A (zh) * 1998-05-12 2001-08-15 美国家用产品公司 用于治疗胰岛素抗性和高血糖的联苯基氧代-乙酸
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
JP2016537398A (ja) * 2013-09-13 2016-12-01 コーテンドー エービー(ピーユービーエル)Cortendo Ab(Publ) 新規なチトクロムp450阻害剤及びこれらの使用方法
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
FI925053L (fi) 1992-11-06
RO109450B1 (ro) 1995-02-28
HUT62894A (en) 1993-06-28
MA22151A1 (fr) 1991-12-31
EP0533695B1 (en) 1994-10-05
WO1991017163A1 (en) 1991-11-14
GT199100031A (es) 1992-10-30
IE911553A1 (en) 1991-11-20
HU9203496D0 (en) 1993-01-28
IL98075A0 (en) 1992-06-21
ZA913497B (en) 1992-12-30
JPH05505619A (ja) 1993-08-19
MY105512A (en) 1994-10-31
DK0533695T3 (da) 1995-01-09
AP224A (en) 1992-10-27
AU7867191A (en) 1991-11-27
PE26691A1 (es) 1991-10-21
AP9100259A0 (en) 1991-07-31
EP0533695A1 (en) 1993-03-31
CA2080476A1 (en) 1991-11-10
CN1057839A (zh) 1992-01-15
BR9106433A (pt) 1993-05-04
DE69104481T2 (de) 1995-02-09
FI925053A7 (fi) 1992-11-06
ATE112567T1 (de) 1994-10-15
YU81191A (sh) 1994-06-10
TW205549B (en, 2012) 1993-05-11
NO924290L (no) 1992-11-06
NO924290D0 (no) 1992-11-06
NZ238089A (en) 1992-10-28
JPH0678340B2 (ja) 1994-10-05
PT97616A (pt) 1992-03-31
BG97059A (bg) 1993-12-24
DE69104481D1 (de) 1994-11-10
AU642265B2 (en) 1993-10-14
FI925053A0 (fi) 1992-11-06

Similar Documents

Publication Publication Date Title
MX9203018A (es) Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados.
DK326588D0 (da) Cyclosporiner
ES2138977T3 (es) Agonistas muscarinicos.
ES2195125T3 (es) Nucleosidos l monociclicos, analogos, y empleos de los mismos.
ES2061247T3 (es) Imidazo (4,5-c) piridinas con actividad antagonista del paf.
ES2184794T3 (es) Profarmacos de morfolina como antagonistas de receptores de taquicininas.
ES2128544T3 (es) Pirrolopirimidinas como antagonistas del crf.
ES2141133T3 (es) Morfolina y tiomorfolina como antagonistas de receptores de taquiquininas.
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
RU94002482A (ru) Пятичленные гетероциклы, смесь их изомеров или отдельные изомеры и их соли
ES2058306T3 (es) Tetralinas substituidas, cromanos y compuestos relacionados en el tratamiento del asma, artritis y enfermedades relacionadas.
ES2181995T3 (es) Derivados de bencimidazol y uso como antagonistas del factor de liberacion de la corticotropina.
CO4480024A1 (es) Nuevos benzopiranos y otros antagonistas de b4(ltb4) leuco- triena fusionada con benzo
IT1200657B (it) Benzammidi sostituite farmacologicamente attive utili per il trattamento della emesi da chemioterapia
ES2169150T3 (es) Compuestos a base de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
CA1236699A (en) RANKINE CYCLE ENERGY PLANT USING ENHANCED ORGANIC FLUID
ES2062202T3 (es) Derivado del indol.
ES2063261T3 (es) 1-(3-(heteroarilmetoxi)fenil) alcanoles sustituidos y compuestos relacionados en el tratamiento de asma, artritis y enfermedades relacionadas.
IT1197713B (it) Dicloro-derivati della serie del 16 alfa-metil pregnano,procedimento per la produzione,loro applicazione come medicamenti e composizioni che li contengono
MX9300409A (es) Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.
ES539242A0 (es) Maquina movil para excavar el balasto de las vias ferreas
ES2062332T3 (es) Benzoxazolonas antiinflamatorias.
MX9305312A (es) 2,4-diazepina aril-fusionada y hetaril-fusionada y agentes antiarritmicosde 2,4-diazocina.
RU94014629A (ru) Производные 4-хинолилдигидропиридина, смесь их изомеров или отдельные изомеры и их соли
ES2152959T3 (es) Utilizacion en perfumeria de isomeros opticamente activos del (e)-3,3-dimetil-5-(2,2,3-trimetil-3-ciclopenten-1-il)-4-penten-2-ol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 533695

Country of ref document: ES